[1]
Gavryliuk, N. et al. 2021. Comparative effectiveness of anti-fibrosis treatment in patients after HCV infection and in patients with non-alcoholic fatty liver disease (NAFLD). Journal of Education, Health and Sport. 11, 2 (Feb. 2021), 222–229. DOI:https://doi.org/10.12775/JEHS.2021.11.02.022.